Background Recent data shows that a prolonged administration of direct thrombin inhibitor might be needed to counteract persistent thrombin activity and reduce the neointimal hyperplasia after arterial injury. We hypothesized that a prolonged administration of LB30057, an orally active direct thrombin inhibitor, might inhibit the vascular smooth muscle cell SMC proliferation in vitro and the neointimal hyperplasia in the rat carotid injury model. Methods In phase I, thrombin stimulated methyl-3 H thymidine uptake was measured after LB30057 administration in cell cultures of rat aortic SMC. In phase II, LB30057 low-dose 5 mg/ kg, bid mid-dose 25 mg/kg, bid high-dose 50 mg/kg, bid or a placebo was administrated orally twice a day starting from 30minutes before the injury until sacrifice after 14days in 2 separate experiments. The histo-morphometric analysis of the lumen area, intimal area, medial area, and the intima-to-medial ratio was determined. Results In the in vitro rat aortic SMC culture experiment, LB30057 inhibited thrombin-induced thymidine uptake. The mean neointimal area was significantly less in the high-dose and mid-dose groups than in the placebo group high-dose vs. placebo 0.14 0.02 mm 2 vs. 0.25 0.02 mm 2 mid-dose vs. placebo 0.16 0.02 mm 2 vs. 0.29 0.03 mm 2 , p 0.005 respectively and the mean ratio of the neointimal to medial area was significantly less in the high-dose and mid-dose groups than in the placebo group high-dose vs. placebo 1.20 0.57 vs. 1.94 0.67, mid-dose vs. placebo 1.58 0.29 vs. 2.39 0.27, p 0.05 . There was no significant difference in the mean area of internal elastic lamina, external elastic lamina and mean luminal area between groups. In 2 nd set experiment, the mean neointimal area placebo 0.29 0.03 mm 2 , middose 0.16 0.02 mm 2 p 0.005 , the mean area of internal elastic lamina and external elastic lamina were significantly less in mid-dose group than in placebo group. The mean ratio of neointima to medial area was significantly less in mid-dose group 1.58 0.29 than in placebo group 2.39 0.27 p 0.05 . Conclusion
LB30057 inhibits SMC proliferation in a dose dependent manner. Prolonged 14-day oral administration of LB30057 is effective in reducing neointimal hyperplasia in the rat carotid balloon injury model. 대조군 대 고용량 군의 비교 2 대조군, 저 용량 군 및 중간 용량 군의 비교 Fig. 4 . Comparison of luminal area LA , intimal area IA and medial area MA between in high dose A or low, mid dose B and control. In 1st set experiment, the mean neointimal area was significantly less in high-dose group than in control group p 0.05 . In 2nd set experiment, the mean neointimal area was significantly less in mid-dose group than in placebo and low dose group p 0.05 .
Fig. 5.
A specimen of the each study group in first set. The neointimal area IA was significantly less in high-dose B group than in control group A p 0.05, H E stain, 40 . Comparison of the effects of the thrombin inhibitor r-hirudin in four animal models of neointima formation after arterial injury. Arterioscler Thromb Vasc Biol 1996 Biol 16 1306 
